AGP Executive Report

Hemp Crackdown Fight: Hawaiʻi officials are defending a crackdown on hemp-derived THC products after a federal lawsuit challenges the state’s move to stop sales that relied on a federal loophole. Medical Cannabis Access: A Rutgers Health study finds older adults rarely discuss cannabis use with clinicians, even as use rises—only about one in five report having those conversations. Policy & Legal Pressure: A new court fight argues the federal marijuana rescheduling push is being implemented before meaningful review is finished, keeping the door open for challenges. Public Health Tech: GS1 CEO says medicine QR codes need stronger standardization across the healthcare supply chain to better verify products and fight counterfeits. Local Enforcement: A Missouri woman faces multiple charges after a crash tied to alleged drug impairment, including methamphetamine and prescription pills. Industry Watch: Ohio’s 2026 crop tour reports promising corn and soybean yield potential despite uneven starts. Safety & Supply: China customs seized 70+ kg of suspected cannabis in a transit case, with two foreigners pleading guilty.

Hemp Policy Fight: Montana hemp processors say a U.S. Senate delay on a planned hemp ban is a “huge win,” buying time after concerns about potent hemp products reaching kids. Public Health & Safety: A pediatrician/ neuroscientist op-ed argues Congress must close the “intoxicating hemp” loophole for delta-8-style products sold like candy, pushing for stronger oversight and age protections. Clinical Research: A new clinical trial report claims oral CBD can ease post-surgery ocular pain as effectively as opioids. Market & Regulation: Texas THC product rules remain in flux as lawsuits and enforcement actions keep reshaping what’s on shelves. Criminal Justice: China prosecutors say two foreign transit passengers pleaded guilty after being caught with 70 kg of cannabis at Beijing airport, despite “in transit” claims. Industry Expansion: Argent BioPharma is pushing into the U.S. with medicinal cannabis therapy for dogs with cancer. Community & Care: A Massachusetts crackdown on kratom continues with emergency orders targeting products.

Hemp Policy Fight: Congress is debating a nationwide ban on hemp-infused products, with Lancaster County businesses and farmers bracing for what it could mean for THC edibles and oils; Montana hemp processors also praised a U.S. Senate delay of a hemp ban, buying time for a longer-term fix. Medical Cannabis Research: New clinical reporting points to oral CBD helping with post-surgery ocular pain as effectively as opioids, while separate studies link medical cannabis to sustained improvements for endometriosis patients and reduced opioid use. Public Health Watch: The CDC is warning of a spike in emergency room visits tied to cannabis hyperemesis syndrome after a new diagnosis code, and UK reporting highlights fatal crashes involving cannabis edibles—fueling calls for tighter safety and education. Industry/Markets: Avicanna posted Q2 2026 results, highlighting growth in proprietary product sales and progress toward profitability. Legal/Enforcement: A drug dealer facing sentencing after a cannabis supply case and multiple international drug seizures keep the spotlight on enforcement pressure around cannabis and other drugs.

Hemp Policy Shock: A Senate delay gives Montana hemp processors and farmers more breathing room as a nationwide ban on many hemp-infused products looms, with local businesses in Lancaster County scrambling for workarounds. Public Health Warning: The CDC says ER visits tied to cannabis hyperemesis syndrome are spiking after a new diagnosis code, with the biggest jump among teens and young adults. Safety & Law: A driver in Lancashire was jailed after killing a mother while driving with cannabis edibles in his system; in Washington, a weed-and-alcohol DUI case ended with a short sentence after years on the run. Medical Cannabis Research: Studies keep pointing to potential benefits for pain and anxiety in endometriosis patients while reducing opioid use, and oral CBD is reported to help post-surgery eye pain as well as opioids. Industry Watch: Avicanna posted Q2 2026 results and is pushing its QUIX™ commercial rollout, while St. Kitts & Nevis opened registration for a Traditional Cultivator Programme. CBD/Cannabis in Daily Life: A “Cannabis Gardener” profile highlights home-growing and CBD teas aimed at calming without getting high.

Kratom Crackdown: Massachusetts is moving fast to restrict kratom, with Gov. Healey issuing an emergency order and local bans following—aimed at products sold in smoke shops and gas stations that regulators say are largely unregulated and can vary in potency. CBD & Hemp Advertising Scrutiny: UK regulators put Katie Price-linked “Supreme CBD” on a non-compliant advertisers list over repeated claims that CBD treats or prevents conditions like anxiety, insomnia, and depression. Medical Cannabis Research (Canada): Canada announced a $24M research push through a national cannabis-and-brain-health consortium to study how cannabis affects mental health and wellbeing across key groups like youth and frequent users. Clinical CBD/Cannabis Science: A new study from UCSF found habitual cannabis inhalers had about 9% fewer premature heartbeats on use days vs abstinent days, adding to the debate over cannabis’s short-term heart effects. Industry Watch: Avicanna reported improved Q2 2026 financials and progress toward commercializing its QUIX™ portfolio. Safety & Policy: A UK case warned a man facing prison after police found 206g of cannabis, with the judge stressing personal accountability.

CBD & Hemp in the Courts: A Bahraini security guard goes on trial accused of hiding hashish and cannabidiol in car cavities, with prosecutors saying he had 2kg+ of hashish for sale. Medical Cannabis Research: A clinical trial report says oral CBD can mitigate post-surgery ocular pain as effectively as opioids. Public Health & Drug Use: Ghana’s NACOC cites 82,500 people using hard drugs (excluding cannabis), with Ashanti Region showing higher HIV prevalence among drug users. Regulation Watch: California begins phasing out paraquat after manufacturers pulled registrations rather than submit health data. Cannabis Policy Abroad: Thailand’s medical-only framework tightens access after the earlier recreational boom, with rules becoming more specific in Bangkok. Safety & Compliance: Airbus details an Air India Phuket-Delhi incident where all three hydraulic systems briefly failed, while separate reporting keeps spotlight on cannabis/drug-testing and pilot medication concerns. Local Community: Estes Land Stewardship runs an Aug 15 weed drop-off to stop seed-spreading noxious weeds.

Kratom Crackdown (Massachusetts): Massachusetts Gov. Maura Healey issued an emergency order moving kratom products into tighter restrictions after FDA warnings about liver toxicity, seizures, and substance-use disorder—while local towns like Deerfield are already banning kratom sales. Medical Cannabis for Endometriosis: A new study reports medical marijuana improves pain, sleep, and anxiety in women with endometriosis and cuts opioid use over 24 months. CBD as Opioid Alternative (Eye Surgery): A randomized trial found oral CBD (low-THC, 25 mg twice daily) matched codeine/acetaminophen for postoperative ocular pain with no adverse effects reported. CDC CHS Update: The CDC says emergency-room visits for cannabis hyperemesis syndrome rose sharply after a new CHS diagnosis code in 2025—likely reflecting better recognition, not a sudden new outbreak. Georgia Medical Cannabis Expansion: Georgia’s medical cannabis program enrollment jumped after lawmakers expanded access to botanical cannabis and higher-THC products, with nearly 45,000 patients now registered. Air Safety & Cannabis: Multiple reports around an Air India pilot incident highlight a positive cannabis test and undisclosed prescription sleep medication, renewing scrutiny on drug disclosure and impairment risk.

Air Travel Safety & Cannabis: Air India ordered mandatory drug screening for all pilots after a Phuket–Delhi incident tied to a marijuana-positive test and a reported 300-foot altitude loss, with the airline saying new checks will go beyond existing rules. Hawaiʻi Hemp Crackdown: Hawaiʻi’s Department of Health moved to stop sales of hemp-derived “mood-altering” smokes and gummies, leaving some shops empty-handed while a seller challenges the crackdown in federal court. Medicinal Cannabis Market: Mississippi’s Sweet Life Canna Co. says its Long Beach facility now supplies 135 dispensaries statewide, highlighting patient-focused production. Research & Health: A study links endometriosis with a higher risk of type 2 diabetes, and a new report warns weed pollen season can extend allergy misery as warmer weather lengthens exposure. CBD Consumer Watch: A hemp brand roundup spotlights which companies provide clear third-party lab access (COAs) for specific batches.

PTSD & sleep: A Nature Medicine trial found prescription dronabinol (THC) cut PTSD nightmare burden over 10 weeks, with more than a third reporting no nightmares. Canada research push: Health Canada announced $24M for a Canadian Cannabis and Brain Health Consortium to study cannabis effects on epilepsy, anxiety, PTSD, sleep, mental health, and youth/pregnancy brain development. Hemp product crackdown (Virginia): Seven Virginia hemp businesses sued to block new consumable hemp limits starting Aug. 15, arguing the rules could bankrupt them. Hemp THC ban delay (Kentucky): Kentucky hemp farmers say an impending federal intoxicating-hemp ban has left huge unsold stock, though a Senate extension to Dec. 11 is giving some hope. Texas shelf risk: Texas regulators say delta-8 and other synthetically derived cannabinoids are now Schedule 1, but experts warn some products may still pose consumer risk. Safety controversy (Air India): Reports tied a pilot’s marijuana-positive tests and sleep-medication claims to a 300-foot loss incident, keeping scrutiny on drug screening and flight fitness. Cardio study: UC San Francisco research suggests inhaled cannabis may reduce premature heartbeats on use days, adding nuance to heart-risk debates. Local policy (Houston): Houston voters will consider deprioritizing enforcement of low-level cannabis possession and banning no-knock warrants.

Cannabis Health Watch: The CDC reports a sharp jump in ER visits tied to cannabis hyperemesis syndrome (CHS) after a new CHS diagnosis code kicked in Oct. 2025, with CHS-related visits rising from 3.35 to 11.26 per 10,000 ED visits and staying elevated through May 2026. Medical Cannabis Access (NY): A New York cohort study in JAMA Internal Medicine found that months with higher medical cannabis dispensing were linked to lower opioid doses among chronic pain patients, though researchers stress it’s an association, not proof. CBD/Oncology Caution: Lab research suggests some cannabinoids may protect glioblastoma cells from chemotherapy and radiation-induced cell death, raising concerns that “anticancer” effects may not be straightforward. Policy & Hemp THC: Texas’ ban on most hemp-derived THC products (except low-dose delta-9) remains in place after a federal judge denied an emergency request to pause it while a lawsuit proceeds. Road Safety: A UK case highlights delta-9 THC driving charges after a blood test found THC above the legal limit, with the driver citing cannabis for pain relief.

Texas Hemp THC Fight: A federal judge refused to pause Texas’ ban on most hemp-derived THC products while a lawsuit plays out, keeping the restrictions in place for now as plaintiffs argue the rules violate the 2018 Farm Bill. PTSD Sleep Breakthrough: A German trial reported prescription THC (dronabinol) helped more than half of severe PTSD patients, with over a third seeing their trauma nightmares disappear. Cannabis Stomach Crisis: ER visits tied to cannabis hyperemesis syndrome (“scromiting”) jumped about 370% after a new diagnosis code made it easier to spot and track. CBD vs. THC Basics: A new explainer breaks down how CBD and THC differ and why that matters for effects and risk. Hemp Drinks Push: Alcohol wholesalers back a bill to keep hemp THC beverages federally legal and regulated like alcohol. Product Compliance: Clean Remedies says it’s changing its lineup in response to evolving federal rules. Local Policy: Alaska’s assembly voted down a proposed 3% marijuana sales tax.

PTSD Treatment Update: A multicenter trial found pharmaceutical THC (dronabinol) oil drops were safe and effective at cutting PTSD-related nightmares, with over a third of patients reporting no nightmares after 10 weeks. CBD/THC Policy Clash: Pennsylvania AG Dave Sunday backed a hemp-derived THC product ban push, arguing it will clarify enforcement—while hemp businesses warn it could shut down legitimate operators. Texas Retail Fallout: A federal judge refused to pause Texas’s THC product ban for now, keeping restrictions in place as hemp retailers argue it harms interstate commerce. CHS/ER Pressure: New reporting highlights how frequent cannabis use is driving more ER visits for cannabis hyperemesis syndrome, including younger users. Medical Cannabis R&D: Artelo Biosciences enrolled its first patient in a Phase 2 glaucoma study of a synthetic cannabinoid receptor agonist aimed at lowering eye pressure without central side effects. Market Watch: A new report projects insulin delivery devices could nearly double to $74.39B by 2035, reflecting rising diabetes demand. Global Enforcement: Customs in Azerbaijan intercepted 25 kg of dried marijuana hidden in pepper shipments from Iran to Russia.

Hemp Legal Fight: A federal judge refused to pause Texas’s THC product ban, leaving the restrictions in place while the case moves forward. State-by-State Pressure: Virginia hemp businesses sued to block new THC limits that would end a key exception, arguing it could wipe out inventory and jobs. Congress Watch: A bipartisan bill would keep hemp THC drinks federally legal and regulated like alcohol, but the Senate also voted to delay the broader hemp THC ban again—showing how messy the rollout is. Clinical Cannabis: A placebo-controlled trial reports a standardized cannabis extract improved autism symptoms in kids and teens with mild, non-serious side effects. Safety Alarm: CDC-linked reporting shows ER diagnoses for cannabis hyperemesis syndrome (“scromiting”) jumped 16% from late 2025 to mid-2026, with more younger users. Medical R&D: Jazz Pharmaceuticals agreed to buy Actio Biosciences for ~$1.3B to expand epilepsy treatments, including a KCNT1 program.

Hemp Legal Fight: Seven Virginia hemp businesses sued to block new consumable THC limits set to hit Aug. 15, arguing the change will wipe out inventory and jobs. Product Safety & Quality: A Frontiers in Pharmacology review of 202 CBD products found big potency misses and frequent contamination flags like heavy metals, solvents, and pesticides—label claims may not match what’s inside. Regulation Abroad: Monaco tightened rules on “legal highs,” adding mushroom compounds (ibotenic acid, muscimol) to its controlled-drug framework and expanding how THC derivatives are classified. Cannabis Health Watch: CDC reporting links a sharp rise in ER cannabis hyperemesis syndrome diagnoses to a new diagnosis code, with the biggest jump among ages 15–24. Medical Cannabis Access: Georgia’s medical cannabis registry surged after eased access rules, jumping over 22% in a month as demand outpaced processing. Clinical Caution (Cosmetic Surgery): A study warns cannabis use disorder is tied to higher postoperative pain and wound-healing complications, urging patients to disclose use for anesthesia and recovery planning. Consumer Reality Check: Ireland’s CBD gummies boom gets an evidence-first review of what CBD does, what’s hype, and where EU law stands.

CDC Update on Cannabis Health Risks: A new CDC report says emergency visits for cannabis hyperemesis syndrome jumped sharply after Oct. 2025, with the authors pointing to a new diagnosis code that made cases easier to spot. Medical Cannabis Access in Georgia: Georgia’s medical cannabis registry surged more than 22% in a month after law changes eased access, overwhelming processing capacity. Hemp Rule Shake-Up in Vermont: Vermont regulators warn a new federal hemp definition could hit CBD-heavy businesses, not just high-THC products. THC Testing & New-Mom Scrutiny: A case highlights how THC test results after childbirth can land people on child abuse registries, even when exposure is accidental. International Enforcement: Hong Kong Customs seized about 6 kg of suspected cannabis buds at the airport, arresting a passenger. CBD Science Watch: Researchers used CRISPR to create hypoallergenic beagles by reducing a key dog allergen protein. Cannabis Use & Stress Biology: Oregon State research links frequent cannabis use with higher morning cortisol, suggesting possible disruption to stress rhythms.

Marijuana & ERs: The CDC reports a 16% jump in emergency-room diagnoses of cannabis hyperemesis syndrome among frequent marijuana users, with researchers pointing to a new diagnosis code that’s making the problem easier to spot. Hemp THC crackdown: The U.S. Senate voted down a move that would have delayed the scheduled hemp THC product ban, keeping pressure on retailers and patients who rely on low-THC hemp options. School vaping gray area: South Carolina districts say they’re finding hemp-derived THC vapes on campus and off-campus, highlighting a legal gap that leaves regulators scrambling. CBD/THC in the spotlight: A Florida pastor accused of sexually abusing a teen while hiding HIV status is tied to a broader wave of public-health and harm concerns around addiction and stigma. Customs bust: Chennai Customs says it seized 4.033 kg of hydroponic ganja from a Malaysian traveler, concealed in false-bottom luggage, and arrested him while tracing a wider network. Clinical pipeline: MIRA Pharmaceuticals posted positive toxicokinetic data for SKNY-1, a cannabinoid-pathway obesity drug candidate, supporting next GLP-toxicology steps. PTSD & mental health: Israel’s mental-health providers report a sharp rise in PTSD and suicides since Oct. 7, underscoring how trauma can overwhelm care systems. Local decriminalization push: Palm Springs backers are seeking city council support to decriminalize certain psychedelic plants and fungi, framing it as education-first policy. Sports & youth policy: Sen. Cory Booker pushes the “Let Kids Play Act,” arguing sports and arts are vital for kids’ success.